Zurcher Kantonalbank (Zurich Cantonalbank) Spring Works Therapeutics, Inc. Transaction History
Zurcher Kantonalbank (Zurich Cantonalbank)
- $34.1 Billion
- Q4 2024
A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 11,685 shares of SWTX stock, worth $566,021. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,685
Previous 9,124
28.07%
Holding current value
$566,021
Previous $292,000
44.52%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding SWTX
# of Institutions
236Shares Held
67.2MCall Options Held
260KPut Options Held
316K-
Vanguard Group Inc Valley Forge, PA7.16MShares$347 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$272 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.46MShares$168 Million5.51% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.27MShares$159 Million0.01% of portfolio
-
State Street Corp Boston, MA3MShares$145 Million0.0% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $3.02B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...